Corton Capital’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$139K Buy
14,208
+244
+2% +$1.88K 0.34% 152
2025
Q2
$84.8K Buy
+13,964
New +$105K 0.1% 319
2023
Q4
Sell
-9,091
Closed -$439K 635
2023
Q3
$439K Buy
9,091
+1,560
+21% +$92.7K 0.22% 124
2023
Q2
$514K Buy
7,531
+3,129
+71% +$202K 0.24% 94
2023
Q1
$213K Buy
+4,402
New +$233K 0.15% 225
2022
Q1
Sell
-14,352
Closed -$709K 478
2021
Q4
$709K Buy
+14,352
New +$796K 0.31% 53

Other funds holding PRTA

Corton Capital's PRTA Position: Q3 2025 in Review

Corton Capital increased its Prothena Corp (PRTA) stake by 1.7% in Q3 2025, buying an estimated $1.88K and bringing the position to 14,208 shares worth $139K. The position accounts for 0.34% of the portfolio, ranked #152.

Corton Capital first reported a position in PRTA in Q4 2021 and has held it in 6 quarters since. The position peaked at $709K in Q4 2021. 187 funds tracked by Wall St. Rank hold PRTA as of Q3 2025.

  • Corton Capital held 14,208 shares of Prothena Corp worth $139K as of Q3 2025.
  • Corton Capital bought 244 Prothena Corp shares in Q3 2025, an estimated $1.88K.
  • Prothena Corp made up 0.34% of Corton Capital's portfolio in Q3 2025, its #152 holding.
  • Corton Capital first reported a position in Prothena Corp in Q4 2021 and has held it in 6 quarters since.
  • Corton Capital's Prothena Corp position peaked at $709K in Q4 2021.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.